Volastra Therapeutics, Inc. is a biotechnology company based in New York City, formed from the laboratory of Dr. Lewis Cantley, along with Drs. Olivier Elemento and Samuel Bakhoum. Volastra is dedicated to the discovery and development of treatments for patients with cancer. The Company’s therapies will target novel pathways and apply insights gained from its scientific founders into chromosomal instability (CIN) and its clear association with the formation, progression, and maintenance of disease. Leveraging these insights we will identify and quickly validate novel therapies to shift the treatment paradigm in the toughest to treat cancers.

Volastra has raised $45M in funding from top US and European venture firms, including Vida, Polaris, Droia, and Arch. Current funding will look to advance a lead program into the clinic, advance another program to IND-enabling studies and strengthen the platform to identify a broader pipeline of candidates. The company has a world class scientific advisory board including two Nobel Laureates as well as a highly experienced senior leadership team. This includes the CEO, CSO and senior leaders with expertise in chemistry, biochemistry, biology, immunology, and operations.

The company operates out of 15,000 square feet of office and state-of-the-art laboratory space in West Harlem, New York City, within easy traveling distance of Columbia, Cornell, Memorial Sloan Kettering, and all most other areas of the city and New Jersey.

Please visit for more information


The role of Biology Intern at Volastra will work closely with the scientific team to achieve the company’s scientific and strategic plan. Volastra is seeking a highly motivated intern for an in vitro biology lab-based role. The intern will have responsibility for designing and executing experiments under the guidance of Volastra scientists to advance programs in Volastra’s pipeline targeting chromosomally unstable (CIN) cancers. Our ideal candidate demonstrates intellectual curiosity and a desire to learn cutting edge techniques in drug development.

Project responsibilities will include, but are not limited to:

1. Validate potential targets of CIN and metastasis using genetic engineering techniques
2. Develop cutting edge 2D and 3D cell culture models to yield new mechanistic insights in CIN biology
3. Work with the team to advance drug development of key programs


1. Independent experience culturing human cell lines in a research laboratory
2. Sterile technique as it pertains to tissue culture
3. Molecular biology techniques such as PCR, RT-qPCR and western blot

Interested candidates can visit for more information or contact Alan Chiu ( directly with a CV and cover letter.

Apply for this Job

* Required